Effects and mechanism of lipoic acid on beta-amyloid-intoxicated C6 glioma cells

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 13880-13888

  Xing, Z G ^a   Yu, G D ^b   Qin, L ^b   Jiang, F ^c   Zhao, W H ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Neurosurgery Department of Xianning Central Hospital   (China)

^c First Affiliated Hospital of Hunan Traditional Chinese Medical College   (China)

Author keywords

C6 glioma cells; Lipoic acid; Oxidative stress; amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; GLUTATHIONE; GLUTATHIONE DISULFIDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; THIOCTIC ACID; AMYLOID BETA PROTEIN; ANTIOXIDANT; SUPEROXIDE DISMUTASE;

ARTICLE; C6 CELL LINE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL LINE; MITOCHONDRION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GLIOMA; METABOLISM; OXIDATION REDUCTION REACTION; RAT; TUMOR CELL LINE;

AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GLIOMA; GLUTATHIONE; GLUTATHIONE DISULFIDE; MITOCHONDRIA; OXIDATION-REDUCTION; RATS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 84946053339     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.October.29.8     Document Type: Article

References (23)

1. Arevalo-Rodriguez I, Segura O, Solà I, Bonfill X, et al. (2014). Diagnostic tools for Alzheimer’s disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurol. 14: 183.
2. Asci H, Saygin M, Cankara FN, Bayram D, et al. (2014). The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity. Ren. Fail. 37: 117-121.
3. Bazin N and Bratu L (2014). Depression in the elderly: prodroma or risk factor for dementia? A critical review of the literature. Geriatr. Psychol. Neuropsychiatr. Vieil. 12: 289-297.
4. Bhadri N, Sanji T, Madakasira Guggilla H and Razdan R (2013). Amelioration of behavioural, biochemical, and neurophysiological deficits by combination of monosodium glutamate with resveratrol/alpha-lipoic acid/coenzyme Q10 in rat model of cisplatin-induced peripheral neuropathy. Sci. World J. 2013: 565813.
5. Bingham PM, Stuart SD and Zachar Z (2014). Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy. Expert. Rev. Clin. Pharmacol. 7: 837-846.
6. Cho N, Lee HK, Jeon BJ, Kim HW, et al. (2014). The effects of Betula platyphylla bark on amyloid beta-induced learning and memory impairment in mice. Food Chem. Toxicol. 74: 156-163.
7. Choi JK, Carreras I, Aytan N, Jenkins-Sahlin E, et al. (2014a). The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer’s disease mouse model using magnetic resonance spectroscopy and imaging. Brain Res. 1590: 85-96.
8. Choi SM, Kim BC, Cho YH, Choi KH, et al. (2014b). Effects of flavonoid compounds on beta-amyloid-peptide-induced neuronal death in cultured mouse cortical neurons. Chonnam. Med. J. 50: 45-51.
9. Di Domenico F, Barone E, Perluigi M and Butterfield DA (2014). Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants. Expert Rev. Neurother. 15: 19-40.
10. Eleuteri S, Di Giovanni S, Rockenstein E, Mante M, et al. (2014). Novel therapeutic strategy for neurodegeneration by blocking Ab seeding mediated aggregation in models of Alzheimer’s disease. Neurobiol. Dis. 74: 144-157.
11. Feng Z and Zhang JT (2004). Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic. Biol. Med. 37: 1790-1801.
12. Forny-Germano L, Lyra e Silva NM, Batista AF, Brito-Moreira J, et al. (2014). Alzheimer’s disease-like pathology induced by amyloid-beta oligomers in nonhuman primates. J. Neurosci. 34: 13629-13643.
13. Guo Y, Jones D, Palmer JL, Forman A, et al. (2014). Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. Support Care Cancer 22: 1223-1231.
14. Hanenberg M, McAfoose J, Kulic L, Welt T, et al. (2014). Amyloid-b peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease. J. Biol. Chem. 289: 27080-27089.
15. Jiang N, Li SY, Xie SS, Li ZR, et al. (2014). Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer’s disease. Eur. J. Med. Chem. 87: 540-551.
16. Mhatre SD, Michelson SJ, Gomes J, Tabb LP, et al. (2014). Development and characterization of an aged onset model of Alzheimer’s disease in Drosophila melanogaster. Exp. Neurol. 261: 772-781.
17. Patel N, Mishra V, Patel P and Dikshit RK (2014). A study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy. J. Diabetes Metab. Disord. 13: 62.
18. Pereira JL, Downes A, Gorgulho A, Patel V, et al. (2014). Alzheimer’s disease: The role for neurosurgery. Surg. Neurol. Int. 5: S385-390.
19. Savioz A, Leuba G and Vallet PG (2014). A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer’s disease. Ageing Res. Rev. 18: 86-94.
20. Tanaka Y, Kaibori M, Miki H, Nakatake R, et al. (2014). Alpha-lipoic acid exerts a liver-protective effect in acute liver injury rats. J. Surg. Res. 193: 675-683.
21. Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, et al. (2014). Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit. Rev. Toxicol. 44: 1-80.
22. Yang Y and Cui M (2014). Radiolabeled bioactive benzoheterocycles for imaging beta-amyloid plaques in Alzheimer’s disease. Eur. J. Med. Chem. 87C: 703-721.
23. Zhang L, Zou J, Chai E, Qi Y, et al. (2014). Alpha-lipoic acid attenuates cardiac hypertrophy via downregulation of PARP-2 and subsequent activation of SIRT-1. Eur. J. Pharmacol. 744: 203-210.